Arbutus Biopharma
ABUS
#7151
Rank
S$0.80 B
Marketcap
S$5.27
Share price
1.49%
Change (1 day)
-10.59%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2026 (TTM): S$0.19 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are S$0.18 Billion. In 2025 the company made an earning of -S$43.17 Million, an increase over its 2024 earnings that were of -S$90.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.19 B-555.16%
2025 -S$43.17 Million-52.09%
2024 -S$90.1 Million-4.02%
2023 -S$93.87 Million12.05%
2022 -S$83.78 Million-14.74%
2021 -S$98.25 Million19.61%
2020 -S$82.14 Million-61.69%
2019 -S$0.22 Billion171.23%
2018 -S$79.05 Million-43.58%
2017 -S$0.15 Billion-77.77%
2016 -S$0.64 Billion532.77%
2015 -S$99.62 Million99.05%
2014 -S$50.05 Million175.82%
2013 -S$18.15 Million-143.7%
2012 S$41.52 M-399.11%
2011 -S$13.89 Million-39.03%
2010 -S$22.77 Million100.55%
2009 -S$11.36 Million-28.56%
2008 -S$15.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-S$2.79 Million-101.41% Bahamas
NRC Health
NRC
S$19.05 M-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA